• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

描述撒哈拉以南非洲抗逆转录病毒治疗项目的扩大规模及成效:一项使用增长曲线的观察性研究

Characterising the scale-up and performance of antiretroviral therapy programmes in sub-Saharan Africa: an observational study using growth curves.

作者信息

Bigelow Benjamin, Verguet Stéphane

机构信息

Independent Researcher, Arlington, Virginia, USA.

Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA

出版信息

BMJ Open. 2020 Sep 28;10(9):e034973. doi: 10.1136/bmjopen-2019-034973.

DOI:10.1136/bmjopen-2019-034973
PMID:32988937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7523223/
Abstract

OBJECTIVES

The rate of change in key health indicators (eg, intervention coverage) is an understudied area of health system performance. Rates of change in health services indicators can augment traditional measures that solely involve the absolute level of performance in those indicators. Growth curves are a class of mathematical models that can parameterise dynamic phenomena and estimate rates of change summarising these phenomena; however, they are not commonly used in global health. We sought to characterise the changes over time in antiretroviral therapy (ART) coverage in sub-Saharan Africa using growth curve models.

DESIGN

This was a retrospective observational study. We used publicly available data on ART coverage levels from 2000 to 2017 in 42 sub-Saharan African countries. We developed two ordinary differential equations models, the Gompertz and logistic growth models, that allowed for the estimation of summary parameters related to scale-up and rates of change in ART coverage. We fitted non-linear regressions for the two models, assessed goodness of fit using the Bayesian information criterion (BIC), and ranked countries based on their estimated performance drawn from the fitted model parameters.

RESULTS

We extracted country performance in rates of scale-up of ART coverage, which ranged from ≤2.5 percentage points per year (South Sudan, Sudan, and Madagascar) to ≥8.0 percentage points per year (Benin, Zimbabwe and Namibia), using the Gompertz model. Based on BIC, the Gompertz model provided a better fit than the logistic growth model for most countries studied.

CONCLUSIONS

Growth curve models can provide benchmarks to assess country performance in ART coverage evolution. They could be a useful approach that yields summary metrics for synthesising country performance in scaling up key health services.

摘要

目标

关键健康指标(如干预覆盖率)的变化率是卫生系统绩效中一个研究不足的领域。卫生服务指标的变化率可以补充那些仅涉及这些指标绝对绩效水平的传统衡量方法。增长曲线是一类数学模型,它可以对动态现象进行参数化,并估计总结这些现象的变化率;然而,它们在全球卫生领域并不常用。我们试图使用增长曲线模型来描述撒哈拉以南非洲地区抗逆转录病毒疗法(ART)覆盖率随时间的变化情况。

设计

这是一项回顾性观察研究。我们使用了2000年至2017年42个撒哈拉以南非洲国家公开可用的ART覆盖率数据。我们开发了两个常微分方程模型,即冈珀茨模型和逻辑增长模型,用于估计与ART覆盖率扩大规模和变化率相关的汇总参数。我们对这两个模型进行了非线性回归,使用贝叶斯信息准则(BIC)评估拟合优度,并根据从拟合模型参数中得出的估计绩效对各国进行排名。

结果

我们使用冈珀茨模型提取了各国在ART覆盖率扩大规模方面的表现,范围从每年≤2.5个百分点(南苏丹、苏丹和马达加斯加)到≥8.0个百分点(贝宁、津巴布韦和纳米比亚)。基于BIC,对于大多数所研究的国家,冈珀茨模型比逻辑增长模型拟合得更好。

结论

增长曲线模型可以为评估各国在ART覆盖率演变方面的表现提供基准。它们可能是一种有用的方法,能够得出汇总指标,以综合各国在扩大关键卫生服务规模方面的表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/c280a9b82232/bmjopen-2019-034973f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/d352828b958f/bmjopen-2019-034973f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/161d0c0c882d/bmjopen-2019-034973f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/b3e90d0996cd/bmjopen-2019-034973f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/9746887e7d34/bmjopen-2019-034973f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/c280a9b82232/bmjopen-2019-034973f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/d352828b958f/bmjopen-2019-034973f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/161d0c0c882d/bmjopen-2019-034973f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/b3e90d0996cd/bmjopen-2019-034973f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/9746887e7d34/bmjopen-2019-034973f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1727/7523223/c280a9b82232/bmjopen-2019-034973f05.jpg

相似文献

1
Characterising the scale-up and performance of antiretroviral therapy programmes in sub-Saharan Africa: an observational study using growth curves.描述撒哈拉以南非洲抗逆转录病毒治疗项目的扩大规模及成效:一项使用增长曲线的观察性研究
BMJ Open. 2020 Sep 28;10(9):e034973. doi: 10.1136/bmjopen-2019-034973.
2
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
3
Human resources for treating HIV/AIDS: needs, capacities, and gaps.治疗艾滋病毒/艾滋病的人力资源:需求、能力与差距。
AIDS Patient Care STDS. 2007 Nov;21(11):799-812. doi: 10.1089/apc.2007.0193.
4
Understanding the Influence of Socioeconomic Environment on Paediatric Antiretroviral Treatment Coverage: Towards Closing Treatment Gaps in Sub-Saharan Africa.了解社会经济环境对儿科抗逆转录病毒治疗覆盖率的影响:努力缩小撒哈拉以南非洲地区的治疗差距。
Cent Eur J Public Health. 2017 Mar;25(1):55-63. doi: 10.21101/cejph.a4479.
5
'Time is costly': modelling the macroeconomic impact of scaling-up antiretroviral treatment in sub-Saharan Africa.“时间成本高昂”:模拟扩大撒哈拉以南非洲地区抗逆转录病毒治疗的宏观经济影响
AIDS. 2008 Jan 2;22(1):107-13. doi: 10.1097/QAD.0b013e3282f1d49f.
6
Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.评估抗逆转录病毒疗法对撒哈拉以南非洲 23 个国家艾滋病毒感染者结核病报告率的影响:2010-2015 年的描述性分析。
BMC Infect Dis. 2018 Sep 26;18(1):481. doi: 10.1186/s12879-018-3387-z.
7
Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.以结核病服务为艾滋病毒治疗的切入点,寻找符合抗逆转录病毒治疗条件的患者。
Trop Med Int Health. 2006 Oct;11(10):1567-75. doi: 10.1111/j.1365-3156.2006.01712.x.
8
Reaching the 'first 90': Gaps in coverage of HIV testing among people living with HIV in 16 African countries.实现“首个90%”:16个非洲国家艾滋病毒感染者的艾滋病毒检测覆盖率差距
PLoS One. 2017 Oct 12;12(10):e0186316. doi: 10.1371/journal.pone.0186316. eCollection 2017.
9
Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.扩大艾滋病毒病毒载量监测范围的进展情况-撒哈拉以南非洲七个国家,2015 年 1 月至 2016 年 6 月。
MMWR Morb Mortal Wkly Rep. 2016 Dec 2;65(47):1332-1335. doi: 10.15585/mmwr.mm6547a2.
10
Impact of ART on the fertility of HIV-positive women in sub-Saharan Africa.抗逆转录病毒治疗对撒哈拉以南非洲地区艾滋病毒阳性女性生育能力的影响。
Trop Med Int Health. 2016 Sep;21(9):1071-85. doi: 10.1111/tmi.12747. Epub 2016 Jul 22.

本文引用的文献

1
Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.博茨瓦纳在实现 2020 年艾滋病署 90-90-90 抗逆转录病毒治疗和病毒学抑制目标方面的进展:一项基于人群的调查。
Lancet HIV. 2016 May;3(5):e221-30. doi: 10.1016/S2352-3018(16)00037-0. Epub 2016 Mar 24.
2
Annual rates of decline in child, maternal, HIV, and tuberculosis mortality across 109 countries of low and middle income from 1990 to 2013: an assessment of the feasibility of post-2015 goals.1990 年至 2013 年期间,109 个中低收入国家儿童、孕产妇、艾滋病毒和结核病死亡率的年度下降率:对 2015 年后目标可行性的评估。
Lancet Glob Health. 2014 Dec;2(12):e698-709. doi: 10.1016/S2214-109X(14)70316-X.
3
Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.2002 年至 2010 年博茨瓦纳国家艾滋病毒/艾滋病治疗方案的结果:纵向分析。
Lancet Glob Health. 2014 Jan;2(1):e44-50. doi: 10.1016/S2214-109X(13)70149-9. Epub 2013 Dec 11.
4
Rwanda 20 years on: investing in life.二十年后的卢旺达:投资生命。
Lancet. 2014 Jul 26;384(9940):371-5. doi: 10.1016/S0140-6736(14)60574-2. Epub 2014 Apr 4.
5
Estimates of performance in the rate of decline of under-five mortality for 113 low- and middle-income countries, 1970-2010.1970年至2010年期间113个低收入和中等收入国家五岁以下儿童死亡率下降率的绩效估计。
Health Policy Plan. 2014 Mar;29(2):151-63. doi: 10.1093/heapol/czs143. Epub 2013 Jan 30.
6
Performance in rate of decline of adult mortality in the OECD, 1970-2010.经合组织(OECD)成人死亡率下降率表现,1970-2010 年。
Health Policy. 2013 Feb;109(2):137-42. doi: 10.1016/j.healthpol.2012.09.013. Epub 2012 Nov 26.
7
An evaluation of R2 as an inadequate measure for nonlinear models in pharmacological and biochemical research: a Monte Carlo approach.R2作为药理学和生化研究中非线性模型的不充分度量的评估:一种蒙特卡罗方法。
BMC Pharmacol. 2010 Jun 7;10:6. doi: 10.1186/1471-2210-10-6.
8
Estimating the lost benefits of antiretroviral drug use in South Africa.估算南非抗逆转录病毒药物使用中损失的益处。
J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):410-5. doi: 10.1097/qai.0b013e31818a6cd5.
9
Modeling of the bacterial growth curve.细菌生长曲线的建模。
Appl Environ Microbiol. 1990 Jun;56(6):1875-81. doi: 10.1128/aem.56.6.1875-1881.1990.
10
Measuring the health of nations: analysis of mortality amenable to health care.衡量各国健康状况:对可通过医疗保健改善的死亡率进行分析。
BMJ. 2003 Nov 15;327(7424):1129. doi: 10.1136/bmj.327.7424.1129.